Interplay between Oxidative Stress and Inflammation in Cardiometabolic Syndrome

Affiliations

¹ Basil Hetzel Institute, University of Adelaide, Woodville South, SA 5011, Australia; Boston University School of Medicine, Boston, MA 02118, USA.
² Kolling Institute, University of Sydney, St Leonards, NSW 2065, Australia.
³ Basil Hetzel Institute, University of Adelaide, Woodville South, SA 5011, Australia.

Editorial

Aaron L Sverdlov et al. Mediators Inflamm. 2016.

. 2016:2016:8254590.

doi: 10.1155/2016/8254590. Epub 2016 Aug 2.

¹ Basil Hetzel Institute, University of Adelaide, Woodville South, SA 5011, Australia; Boston University School of Medicine, Boston, MA 02118, USA.
² Kolling Institute, University of Sydney, St Leonards, NSW 2065, Australia.
³ Basil Hetzel Institute, University of Adelaide, Woodville South, SA 5011, Australia.

No abstract available

References

1. Thomas D. M., Weedermann M., Fuemmeler B. F., et al. Dynamic model predicting overweight, obesity, and extreme obesity prevalence trends. Obesity. 2014;22(2):590–597. doi: 10.1002/oby.20520. - DOI - PMC - PubMed
1. Park Y.-W., Zhu S., Palaniappan L., Heshka S., Carnethon M. R., Heymsfield S. B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Archives of Internal Medicine. 2003;163(4):427–436. doi: 10.1001/archinte.163.4.427. - DOI - PMC - PubMed
1. Sverdlov A. L., Elezaby A., Qin F., et al. Mitochondrial reactive oxygen species mediate cardiac structural, functional, and mitochondrial consequences of diet-induced metabolic heart disease. Journal of the American Heart Association. 2016;5 doi: 10.1161/JAHA.115.002555.e002555 - DOI - PMC - PubMed
1. Rasmussen H. H., Hamilton E. J., Liu C.-C., Figtree G. A. Reversible oxidative modification: implications for cardiovascular physiology and pathophysiology. Trends in Cardiovascular Medicine. 2010;20(3):85–90. doi: 10.1016/j.tcm.2010.06.002. - DOI - PubMed
1. Ngo D. T. M., Farb M. G., Kikuchi R., et al. Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity. Circulation. 2014;130(13):1072–1080. doi: 10.1161/circulationaha.113.008171. - DOI - PMC - PubMed